Point prevalence survey of antibiotic use in hospitals in Latin American countries
- PMID: 34957520
 - PMCID: PMC9092443
 - DOI: 10.1093/jac/dkab459
 
Point prevalence survey of antibiotic use in hospitals in Latin American countries
Erratum in
- 
  
  Correction to: Point prevalence survey of antibiotic use in hospitals in Latin American countries.J Antimicrob Chemother. 2022 Jun 29;77(7):2051. doi: 10.1093/jac/dkac120. J Antimicrob Chemother. 2022. PMID: 35451024 Free PMC article. No abstract available.
 
Abstract
Background: Point prevalence surveys (PPSs) on antibiotic use are useful for understanding different aspects related to prescription patterns in hospitals.
Methods: An adaptation of the WHO methodology for a PPS on antibiotic use was applied. Hospital wards were divided into medical (MED), surgical (SUR), ICUs, gynaecology and obstetrics (GO), high-risk (HR) and mixed wards (MIX). A web application (RedCap©) through a mobile device was used for data collection.
Results: Between December 2018 and August 2019, 5444 patients in 33 hospitals in five countries were included (10 hospitals in Cuba, 7 in Paraguay, 6 in El Salvador, 5 in Mexico and 5 in Peru). Of these patients, 54.6% received at least one antibiotic, with variations between and within hospitals and countries. Antibiotics were more frequently used in ICUs (67.2%), SUR (64.5%) and MED wards (54.2%), with 51.2% of antibiotics prescribed for community-acquired infections (CAIs), 22.9% for healthcare-associated infections (HAIs), 11.1% for surgical prophylaxis and 6.1% for unknown reasons. Adherence to guidelines was observed in 68.6% of cases (72.8% for CAIs, 72.4% for HAIs and 44.3% for prophylaxis). Third-generation cephalosporins were the class of antibiotics most frequently used (26.8%), followed by carbapenems (10.3%) and fluoroquinolones (8%). Targeted treatments were achieved in 17.3% of cases.
Conclusions: Antibiotic use was generally higher than that published in other studies. There is an urgent need to promote and strengthen the antimicrobial stewardship programmes in Latin America.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Figures
              
              
              
              
                
                
                References
- 
    
- Laxminarayan R, Van Boeckel T, Frost I. et al. The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later. Lancet Infect Dis 2020; 20: e51–60. - PubMed
 
 - 
    
- WHO. Sixty-eighth World Health Assembly, Geneva, 18–26 May 2015: resolutions and decisions: annexes. https://apps.who.int/iris/handle/10665/253469.
 
 - 
    
- WHO. WHO methodology for point prevalence survey on antibiotic use in hospitals, version 1.1. 2018. https://apps.who.int/iris/handle/10665/280063.
 
 - 
    
- Zarb P, Goossens H.. European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe. Drugs 2011; 71: 745–55. - PubMed
 
 - 
    
- Versporten A, Zarb P, Caniaux I. et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health 2018; 6: e619–29. - PubMed
 
 
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
